University of California San Francisco

Give to UCSF

Special Notice Concerning COVID-19

Learn about UCSF’s response to the coronavirus outbreak, important updates on campus safety precautions, and the latest policies and guidance on our COVID-19 resource website. You can also access information from the CDC. Learn more

Advanced
297 Results in the UCSF News Center
Type of Article
Areas of Focus
Date of Publication
Health And Science Topics
Campus Topics
Displaying 271 - 297 of 297
  • What Steers Vampires to Blood

    Scientists have known for years that when vampire bats tear through an animal’s skin with their razor-sharp teeth, their noses guide them to the best spots – where a precise bite will strike a vein and spill forth nourishing blood. But nobody knew exactly how bats knew where to bite – until now.

    Placeholder image
  • UCSF Team Describes Genetic Basis of Rare Human Diseases

    Researchers at UCSF and in Michigan, North Carolina and Spain have discovered how genetic mutations cause a number of rare human diseases, which include Meckel syndrome, Joubert syndrome and several other disorders.

    Placeholder image
  • Mining the Human Body with Michael Fischbach, PhD

    <p>Having developed an algorithm that discovered a large quantity of drug-producing bacteria in and on humans, Fischbach has turned his lab’s attention to studying their populations and interactions with each other. This, he posits, can greatly influence a person’s overall health and disease.</p>

    Placeholder image
  • Smarter Drug Delivery with Tejal Desai, PhD

    <p>Swallowing pills means medication must face the challenge of surviving the harsh environment of the digestive tract. As a result, people must take larger doses than they need. Using micro and nano-fabrication techniques developed by the computer chip industry, Desai’s lab is creating tiny devices that take multiple drugs directly to where they are needed, using less medication, minimizing side effects and making the process safer for the patient.&nbsp;</p>

    Placeholder image
  • UCSF Joins Caltech in Creative Problem Solving to Advance Health Care

    <p>Experts at UCSF and Caltech are pushing the boundaries of creative problem solving to address important clinical problems with the hope that the talent pool at both institutions, combined with an entrepreneurial spirit, will advance health care innovation.</p>

    Placeholder image
  • Men's and Women's Immune Systems Respond Differently to PTSD

    Men and women had starkly different immune system responses to chronic post-traumatic stress disorder, with men showing no response and women showing a strong response, in two studies by researchers at the San Francisco VA Medical Center and the University of California, San Francisco.

    Placeholder image
  • UCSF Team Shows How to Make Skinny Worms Fat and Fat Worms Skinny

    Researchers exploring human metabolism at UCSF have uncovered a handful of chemical compounds that regulate fat storage in worms, offering a new tool for understanding obesity and finding future treatments for diseases associated with obesity.

    Placeholder image
  • UCSF Team Views Genome As It Turns On and Off Inside Cells

    UCSF researchers have developed a new approach to decoding the vast information embedded in an organism’s genome, while shedding light on exactly how cells interpret their genetic material to create RNA messages and launch new processes in the cell.

    Placeholder image
  • UCSF Gene Therapy Method Allays Parkinson's Symptoms

    A novel technique created at UCSF to deliver a growth factor directly to brain cells has shown promising results in treating Parkinson's symptoms and could enter human clinical trials as early as next year.

    Placeholder image
  • McKerrow's Parasitic Disease Research Garners Mendel Medal

    James McKerrow, leader of the Sandler Center for Drug Discovery at UCSF, was honored with the 2009 Mendel Medal for his work identifying the vulnerabilities of disease-causing parasites and for devising new strategies to fight them.

    Placeholder image
  • New kidney transplant drug effective in humans, UCSF study finds

    UCSF nephrologist Flavio Vincenti, MD, is the lead author of a paper in the March 2010 issue of the <i>American Journal of Transplantation</i> that reports results from a Phase III clinical trial for a new drug that selectively blocks immune suppression for kidney transplants. The drug, belatacept, is given to kidney-transplant recipients to prevent the immune system from rejecting the new organ. Vincenti and his co-investigators found that belatacept may be as effective as the commonly used anti-rejection drug cyclosporine, but with fewer side effects and superior kidney function after 12 months.

    Placeholder image
  • Gene family found to play key role in early stages of development

    Scientists have identified a gene family that plays a key role in one of the earliest stages of development in which an embryo distinguishes its left side from the right and determines how organs should be positioned within the body. The finding in mice likely will lead to a better understanding of how certain birth defects occur in humans.

    Placeholder image
  • Telomeres and the Remarkable Telomerase Enzyme

    Telomeres — which are the DNA repeats that form the tips of chromosomes and are produced by the telomerase enzyme — play a crucial, and curious, role in the life of the cell.

    Placeholder image